Yahoo · Nov 11, 2026
Has Santen Pharmaceutical (TSE:4536) Earned Its 56% Rise And Buyback Support?
Santen Pharmaceutical has logged a strong run in recent years, and the question now is whether that climb is fully explained by what the business earns. With the stock price moving ahead, the key issue is how closely that market enthusiasm lines up with Santen Pharmaceutical's earnings power. Over the past 3 years the share price has returned 56.1%, which puts real weight on the question of whether current earnings can carry that kind of gain. The newly approved share buyback program, which...

